GROWTH FACTORS: ROLES IN ANDROLOGY

REFERENCES

• Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR (1994): Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91:1074–1078.
   PubMed Web of Science ®Google Scholar
• Bonkhoff H, Remberger K (1996): Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28:98–106.
   PubMed Web of Science ®Google Scholar
• Cheifetz S, Hernandez H, Laiho M, ten Dijke P, Iwata KK, Massague J (1990): Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 265:20533–20538.
   PubMed Web of Science ®Google Scholar
• Coffey DS (1993): The molecular biology of the prostate. In: Prostate diseases. Lepor H, Lawson RK (Eds). Philadelphia: Saunders, pp 28–56.
   Google Scholar
• Cohen DW, Simak R, Fair WR, Melded J, Scher HI, Cordon-Cardo C (1994): Expression of trans-forming growth factor-alpha and the epidermal growth factor receptor in human prostatic tissue. J Urol 152:2120–2124.
   PubMed Web of Science ®Google Scholar
• Cohen P, Peehl D, Lamson G, Rosenfeld RG (1991): Insulin-like growth factors (IGFs), IGF recep-tors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73:401–407.
   PubMed Web of Science ®Google Scholar
• Cunha GR, Foster B, Thompson A, Sugimura Y, Tanji N, Tsuji M, Terada N, Finch PW, Donjacour AA (1995): Growth factors as mediators of androgen action during the development of the male urogenital tract. World J Urol 13:264–276.
   PubMed Web of Science ®Google Scholar
• Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA (1992): Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal—epithelial interactions and growth factors. J Androl 13:465–475.
   PubMedGoogle Scholar
• Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y (1987): The endocrinology and developmental biology of the prostate. Endocr Rev 8:338–362.
   PubMed Web of Science ®Google Scholar
• Cunha GR (1985): Mesenchymal-epithelial interactions during androgen-induced development of the prostate. Prog Clin Biol Res 171:15–24.
   PubMedGoogle Scholar
• Finch PW, Rubin JS, Miki A (1989): Human KGF is FGF-related with properties of a paracrine effecter of epithelial cells. Science 245:752–755.
   PubMed Web of Science ®Google Scholar
• Fiorelli G, De Bellis A, Longo A, Giannini S, Natali A, Costantini A, Vannelli GB, Serio M (1991): Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone ana-log. J Clin Endocrinol Metab 72:740–746.
   PubMed Web of Science ®Google Scholar
• Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, Derynck R (1989): Human transforming growth factor-beta 3; recombinant expression, purification and biological activities comparison with transforming growth factors-beta 1 and -beta 2. Mol Endocrinol 3:1977–1986.
   Google Scholar
• Habib FK (1994): The role of growth factors in the pathogenesis of BPH. Prog Clin Biol Res 386: 43–50.
   PubMedGoogle Scholar
• Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, Day ML (1995): Hepato-cyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147:386–396.
   Google Scholar
• Jakowlew SB, Dillard PJ, Kondaiah P, Sporn MB, Roberts AB (1988): Complimentary deoxyribo-nucleic acid from chick embryo chondrocytes. Mol Endocrinol 2:747–755.
   PubMed Web of Science ®Google Scholar
• Kim TY, Ahn HJ, Zelner DJ, Park L, Sensiber JA, Lee C (1996): Expression and localization of transforming growth factor beta type I and II receptors in the rat ventral prostate during regression. Mol Endocrinol 10:107–115.
   PubMedGoogle Scholar
• Kondaiah P, Sands MJ, Smith JIM, Fields A, Roberts AB, Sporn MB, Melton DA (1990): Identifica-tion of a novel transforming growth factor-f3 (TGF-f35) mRNA in Xenopus laevis. J Biol Chem 265:1089–1093.
   PubMed Web of Science ®Google Scholar
• Kyprianou N, Isaacs IT (1989): Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515–1522.
   PubMedGoogle Scholar
• Landstorm M, Eklov S, Colosetti P, Nilsson S, Damber JE, Bergh A, Funa K (1996): Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors. Int J Cancer 67:573–579.
   PubMed Web of Science ®Google Scholar
• Lee DC, Rochford RM, Todaro GJ, Villareal LP (1985): Developmental expression of rat transform-ing growth factor-a mRNA. Mol Cell Biol 5:3644–3646.
   PubMed Web of Science ®Google Scholar
• Massague J, Cheifetz S, Boyd FT, Andres JL (1990): TGF-beta receptors and TGF-beta binding proteoglycans: recent progress in identifying their functional properties. Ann NY Acad Sci 593:59–72.
   PubMed Web of Science ®Google Scholar
• Massague J (1987): The TGF-f3 family of growth and differentiation factors. Cell 49:437–438.
   PubMed Web of Science ®Google Scholar
• Nemeth JA, Sensibar JA, White RR, Zelner DJ, Kim TY, Lee C (1997): Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-01. Prostate 33:64–71.
   PubMed Web of Science ®Google Scholar
• Nishi N, Oya H, Matsumoto K, Nakamura T, Miyanaka H, Wada F (1996): Changes in gene expres-sion of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates. Prostate 28:139–152.
   PubMed Web of Science ®Google Scholar
• Peehl DM, Wong ST, Rubin JS (1996): KGF and EGF differentially regulate the phenotype of pros-tatic epithelial cells. Growth Regul 6:22–31.
   PubMedGoogle Scholar
• Peehl DM, Wong S, Bazinet M, Stamey TA (1989): In vitro studies human prostatic epithelial cells: attempts to identify distinguishing features of malignant cells. Growth Factors 1:237–250.
   PubMed Web of Science ®Google Scholar
• Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW (1995): c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol 154:293–298.
   PubMed Web of Science ®Google Scholar
• Rappolee DA, Brenner CA, Schultz R, Mark D, Werb Z (1988): Developmental expression of PDGF, TGF-alpha, and TGF-f3 genes in preimplantation mouse embryos. Science 241:1823–1825.
   Web of Science ®Google Scholar
• Ruan W, Powell-Braxton L, Kopchick JJ, Kleinberg DL (1999): Evidence that insulin-like growth fac-tor I and growth hormone are required for prostate gland development. Endocrinology 140:1984–1989.
   PubMed Web of Science ®Google Scholar
• Russell PJ, Bennett S, Sticker P (1998): Growth factor involvement in progression of prostate cancer. Clin Chem 44:705–723.
   PubMed Web of Science ®Google Scholar
• Schuurmans AL, Bolt J, Mulder E (1988): Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP). Mol Cell Endocrinol 60:101–104.
   PubMed Web of Science ®Google Scholar
• Sherwood ER, Lee C (1995): Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol 13:290–296.
   PubMed Web of Science ®Google Scholar
• St Arnaud R, Poyet P, Walker P, Labrie F (1988): Androgen modulate epidermal growth factor ex-pression in the rat ventral prostate. Mol Cell Endocrinol 56:21–27.
   PubMed Web of Science ®Google Scholar
• Steiner MS (1993): Role of peptide growth factors in the prostate: a review. Urology 42:99–110.
   PubMed Web of Science ®Google Scholar
• Stiles CD, Capone G, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ (1979): Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 76:1279–1283.
   PubMed Web of Science ®Google Scholar
• Story MT, Hopp KA, Meier D (1996): Regulation of basic fibroblast growth factor expression by transforming growth factor in cultured human prostate stroma cells. Prostate 28:219–226.
   Google Scholar
• Story MT, Hopp KA, Molter M, Meier DA (1992): Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 10:269–280.
   Web of Science ®Google Scholar
• Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J, Cunha GR (1996): Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol 40:941–951.
   PubMed Web of Science ®Google Scholar
• Tanji N, Tsuji M, Terada N, Takeuchi M, Cunha GR (1994): Inhibitory effects of transforming growth factor-f3 on androgen-induced development of neonatal mouse seminal vesicles in vitro. Endocrinol-ogy 134:1155–1162.
   PubMed Web of Science ®Google Scholar
• Taylor TB, Ramsdell JS (1993): Transforming growth factor-alpha and its receptor are expressed in the epithelium of the rat prostate gland. Endocrinology 133:1306–1311.
   PubMed Web of Science ®Google Scholar
• Tenniswood M (1986): Role of epithelial-stromal interactions in the control of gene expression in the prostate: an hypothesis. Prostate 9:375–385.
   PubMed Web of Science ®Google Scholar
• Timme TL, Truong LD, Slavin KM, Kadmon D, Park SH, Thompson TC (1995): Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth. Microsc Res Tech 30:333–341.
   PubMed Web of Science ®Google Scholar
• Traish AM, Wotiz HH (1987): Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 121:1461–1490.
   PubMed Web of Science ®Google Scholar
• Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984): Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309:418–424.
   PubMed Web of Science ®Google Scholar
• Winkler ME, O'Conner L, Winget M, Fendly B (1989): Epidermal growth factor and transforming growth factor a bind differently to the epidermal growth factor receptor. Biochemistry 28:6373–6378.
   PubMed Web of Science ®Google Scholar
• Wong YC, Wang YZ (2000): Growth factors and epithelial-stromal interactions in prostate cancer development. Int Rev Cytol 199:65–116.
   PubMed Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, Ventura F, Massague J (1994): Mechanism of activation of the TGF-beta receptor. Nature 370:341–347.
   PubMed Web of Science ®Google Scholar
• Yan SD, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL (1992): Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6:2123–2128.
   PubMed Web of Science ®Google Scholar